ZNF451 (NM_001031623) Human Untagged Clone

CAT#: SC302520

ZNF451 (untagged)-Human zinc finger protein 451 (ZNF451), transcript variant 1



  "NM_001031623" in other vectors (6)

CNY 20,430.00


货期*
4周

规格
    • 10 ug

Product images

经常一起买 (4)
ZNF451 Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4,090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1,280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Synonyms COASTER; dJ417I1.1
Vector pCMV6-Entry
E. coli Selection Kanamycin (25 ug/mL)
Mammalian Cell Selection Neomycin
Sequence Data
>SC302520 representing NM_001031623.
Blue=Insert sequence Red=Cloning site Green=Tag(s)

GCTCGTTTAGTGAACCGTCAGAATTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTG
GATCCGGTACCGAGGAGATCTGCCGCCGCGATCGCC
ATGGGAGACCCGGGGTCGGAGATAATAGAATCTGTCCCTCCAGCTGGCCCTGAGGCATCTGAGTCAACA
ACGGATGAAAATGAAGACGACATTCAGTTTGTCAGTGAAGGACCATTACGACCTGTTCTTGAATACATT
GATCTGGTCAGCAGTGATGATGAAGAGCCTAGCACCTCTTATACTGATGAGAATATTAAACGTAAAGAC
CATATTGATTATCAGAAGGATAAAGTTGCTTTAACTCTGGCTCGTCTAGCCCGCCATGTTGAAGTGGAG
AAACAGCAGAAAGAAGAGAAGAATAGAGCATTCAGAGAAAAAATTGATTTTCAGCATGCTCATGGGTTA
CAAGAATTGGAATTTATTCGAGGACATTCTGATACAGAAGCAGCAAGACTGTGTGTGGACCAGTGGCTA
AAAATGCCAGGACTCAAAACAGGCACAATTAATTGTGGAACAAAAAGTTCATTCCGAAGAGGAGGCCAC
ACGTGGGTGTCTGGGAAACCAATTTTATGTCCTATAATGCACTGTAACAAGGAGTTTGACAATGGGCAC
CTTCTCTTAGGACATTTGAAAAGGTTCGATCACTCTCCATGTGATCCAACAATTACACTACATGGACCT
TTCTTCAGCTCCTTTGCTTGTGTAGTATGTTATAAAAAATTTGTTACTCAACAACAATATAGAGATCAC
CTTTTTGATAAGGAAGCCACAGATGATGGACATAACAACAACCTTCTTCCTCAGATTATTCAGTGTTTT
GCATGTCCAAATTGCTTCCTTCTTTTTAGCAGAAAGGAGGAGTGTTCAAAGCATATGTCTGGAAAGAAT
CATTTCCATCAGAGTTTCAAACTGGGTGATAACAAAGGAATTGCACATCCAATATCTTTCCCATCTTTT
GCAAAGAAACTTTTGATCTCTCTGTGCAAAGATGTTCCCTTTCAAGTTAAGTGTGTGGCCTGCCACAAG
ACACTGCGTTCCCACATGGAGCTCACTGCCCATTTCAGAGTTCATTGTCGAAATGCTGGACCTGTAGCT
GTAGCTGAGAAGAGCATTACCCAGGTTGCAGAGAAATTCATATTAAGAGGTTATTGTCCAGATTGCAAT
CAAGTCTTTGTGGATGAAACCAGCACCCAAAATCATAAGCAGAATTCAGGACACAAAGTCCGAGTCATT
AACTCAGTGGAAGAATCAGTCTTACTCTATTGCCACAGCAGCGAAGGGAACAAGGATCCTTCTTCTGAC
TTGCATTTATTGTTGGATCAATCAAAATTTTCATCACTTAAAAGAACCATGTCTATTAAAGAATCTAGC
TCACTGGAGTGCATTGCCATTCCAAAAAAGAAGATGAATTTAAAAGATAAAAGCCATGAAGGTGTTGCT
TGTGTCCAGAAAGAAAAATCAGTAGTTAAAACCTGGTTCTGTGAATGCAATCAGCGATTCCCAAGTGAA
GATGCAGTAGAAAAGCATGTTTTCTCAGCAAACACAATGGGTTATAAATGTGTGGTCTGTGGAAAGGTA
TGTGATGATTCAGGGGTCATTCGTTTACACATGAGCCGGATTCACGGAGGGGCACATTTAAATAACTTT
CTTTTCTGGTGTCGGACATGCAAAAAGGAGTTAACAAGGAAAGATACTATCATGGCACATGTGACTGAA
TTTCATAATGGACACAGATATTTTTATGAGATGGATGAGGTAGAAGGTGAAACTTTGCCATCATCCTCT
ACAACATTGGATAATTTGACTGCTAACAAGCCTTCATCAGCTATTACTGTTATTGATCATTCCCCGGCA
AATAGTTCTCCGAGGGGTAAATGGCAATGCCGGATTTGTGAAGATATGTTTGATTCCCAGGAATATGTA
AAACAGCACTGCATGTCTTTGGCAAGCCACAAGTTTCATAGATACAGCTGTGCTCACTGCAGAAAGCCT
TTTCATAAGATAGAAACATTGTACCGACATTGCCAAGATGAGCATGACAATGAGATAAAGATTAAATAC
TTCTGTGGGCTTTGTGATCTTATCTTTAATGTGGAAGAAGCATTTCTGAGTCATTATGAGGAGCACCAC
AGCATAGATTATGTATTTGTGTCAGAAAAAACTGAAACTTCAATTAAAACCGAAGATGATTTTCCAGTA
ATAGAGACCAGTAACCAGTTAACTTGTGGTTGCCGTGAGAGTTACATCTGTAAAGTCAACAGAAAAGAA
GATTATAGCAGATGTCTCCAAATCATGCTGGATAAAGGAAAACTGTGGTTTCGCTGCAGTTTATGTTCG
GCAACAGCACAGAATTTAACCGACATGAACACTCATATCCATCAAGTGCACAAAGAAAAGAGTGATGAG
GAGGAGCAGCAGTATGTAATCAAGTGTGGCACCTGCACCAAAGCATTTCATGATCCTGAGAGTGCACAG
CAGCATTTCCATAGAAAACATTGCTTCTTACAGAAACCCAGTGTGGCTCATTTTGGATCTGAAAAATCA
AACCTGTACAAGTTTACTGCTAGTGCCTCACATACAGAGAGAAAACTGAAACAGGCAATAAACTATTCA
AAAAGTTTAGACATGGAGAAAGGAGTTGAGAATGACCTAAGCTATCAGAATATAGAGGAAGAAATTGTT
GAGCTTCCAGATTTGGATTACCTGCGAACCATGACTCATATAGTCTTTGTAGATTTTGATAACTGGTCA
AACTTTTTTGGTCATCTACCAGGGCATCTAAACCAAGGAACATTTATTTGGGGCTTTCAAGGAGGAAAC
ACCAATTGGAAGCCTCCGCTCAACTGTAAGATTTATAACTACCTGAACAGGATTGGATGCTTCTTCCTT
CATCCTCGCTGTAGTAAAAGAAAAGATGCTGCTGATTTTGCCATATGTATGCATGCTGGCCGTCTAGAT
GAACAACTACCCAAGCAAATTCCTTTCACCATCCTCTCAGGAGATCAAGGTTTTCTGGAGCTAGAGAAT
CAATTTAAGAAGACTCAGAGGCCAGCTCATATACTAAACCCTCACCACTTAGAGGGAGATATGATGTGT
GCCTTGTTAAATAGCATATCTGATACCACCAAAGAATGTGACAGTGATGATAACATGGGTGCCAAAAAT
ACTTCAATAGGAGAAGAATTTATATCCACAGAAGATGTGGAATTAGAAGAAGCTATTAGAAGAAGTCTT
GAGGAAATGTAA

ACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGATATCCTGGAT
TACAAGGATGACGACGATAAG
GTTTAAACGGCCGGC
Restriction Sites SgfI-MluI     
ACCN NM_001031623
Insert Size 3186 bp
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
OTI Annotation This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Reference Data
RefSeq NM_001031623.2
RefSeq Size 5241 bp
RefSeq ORF 3186 bp
Locus ID 26036
UniProt ID Q9Y4E5
Protein Families Transcription Factors
MW 121.5 kDa
Gene Summary E3 SUMO-protein ligase; has a preference for SUMO2 and SUMO3 and facilitates UBE2I/UBC9-mediated sumoylation of target proteins (PubMed:26524493, PubMed:26524494). Plays a role in protein SUMO2 modification in response to stress caused by DNA damage and by proteasome inhibitors (in vitro). Required for MCM4 sumoylation (By similarity). Has no activity with SUMO1 (PubMed:26524493). Preferentially transfers an additional SUMO2 chain onto the SUMO2 consensus site 'Lys-11' (PubMed:26524493). Negatively regulates transcriptional activation mediated by the SMAD4 complex in response to TGF-beta signaling. Inhibits EP300-mediated acetylation of histone H3 at 'Lys-9' (PubMed:24324267). Plays a role in regulating the transcription of AR targets (PubMed:18656483).[UniProtKB/Swiss-Prot Function]
Transcript Variant: This variant (1) encodes the longest isoform (1).
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...